Literature DB >> 16024854

Comparison of retinal nerve fibre layer thickness and visual field loss between different glaucoma groups.

R P Galvão Filho1, R M Vessani, R Susanna.   

Abstract

BACKGROUND/AIMS: Scanning laser polarimetry (SLP) uses a confocal scanning laser ophthalmoscope with an integrated polarimeter to evaluate the thickness of the retinal nerve fibre layer (RNFL). The aim of this study was to verify the ability of the SLP to detect differences in RNFL thickness between normal and glaucomatous eyes and between glaucomatous eyes subdivided in groups by the severity of visual field damage.
METHODS: This was a cross sectional retrospective study. The charts of 40 healthy subjects and 68 glaucoma patients who underwent complete ophthalmological examination, optic disc stereophotography, peripapillary, and macular SLP imaging were reviewed. The right eye of subjects eligible for the study was enrolled. Only eyes with SLP examinations indicating a minimised effect of anterior segment birefringence based on macular image were included. The ability of retardation parameters to discriminate between healthy and glaucomatous eyes was evaluated. Based on visual field loss, glaucoma patients were subdivided in three subgroups (early, moderate, and severe). RNFL thickness between healthy control group and glaucoma subgroups was compared. RNFL thickness and visual field loss correlation was evaluated.
RESULTS: There was a significant difference in superior and inferior maximum RNFL thickness between normal and glaucomatous eyes (p<0.001). With these two parameters, the area under receiver operator characteristic curve was 0.75 and 0.74, respectively. Superior and inferior RNFL thickness was significantly different between healthy control group and all glaucoma subgroups (p<0.001) and between glaucoma subgroups (p<0.05), except for early and moderate glaucoma subgroups (p>0.05). Linear regression showed a weak correlation between RNFL thickness and visual field loss.
CONCLUSION: These results suggest that once visual field loss is established, smaller reductions in the RNFL thickness detected by SLP are necessary for a given reduction of mean defect value.

Entities:  

Mesh:

Year:  2005        PMID: 16024854      PMCID: PMC1772786          DOI: 10.1136/bjo.2004.050906

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  14 in total

1.  Correlation of automated visual field parameters and peripapillary nerve fiber layer thickness as measured by scanning laser polarimetry.

Authors:  Y H Kwon; S Hong; R A Honkanen; W L Alward
Journal:  J Glaucoma       Date:  2000-08       Impact factor: 2.503

2.  Individualized compensation of anterior segment birefringence during scanning laser polarimetry.

Authors:  Qienyuan Zhou; Robert N Weinreb
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-07       Impact factor: 4.799

3.  Measurement of the magnitude and axis of corneal polarization with scanning laser polarimetry.

Authors:  Robert N Weinreb; Christopher Bowd; David S Greenfield; Linda M Zangwill
Journal:  Arch Ophthalmol       Date:  2002-07

4.  Variation of nerve fibre layer thickness measurements with age and ethnicity by scanning laser polarimetry.

Authors:  D Poinoosawmy; L Fontana; J X Wu; F W Fitzke; R A Hitchings
Journal:  Br J Ophthalmol       Date:  1997-05       Impact factor: 4.638

5.  Association between quantitative nerve fiber layer measurement and visual field loss in glaucoma.

Authors:  R N Weinreb; S Shakiba; P A Sample; S Shahrokni; S van Horn; V S Garden; S Asawaphureekorn; L Zangwill
Journal:  Am J Ophthalmol       Date:  1995-12       Impact factor: 5.258

6.  Detecting early glaucoma by assessment of retinal nerve fiber layer thickness and visual function.

Authors:  C Bowd; L M Zangwill; C C Berry; E Z Blumenthal; C Vasile; C Sanchez-Galeana; C F Bosworth; P A Sample; R N Weinreb
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-08       Impact factor: 4.799

7.  Reproducibility of retardation measurements with the nerve fiber analyzer II.

Authors:  L Zangwill; C A Berry; V S Garden; R N Weinreb
Journal:  J Glaucoma       Date:  1997-12       Impact factor: 2.503

8.  Stability of corneal polarization axis measurements for scanning laser polarimetry.

Authors:  D S Greenfield; R W Knighton
Journal:  Ophthalmology       Date:  2001-06       Impact factor: 12.079

9.  Optic nerve damage in human glaucoma. III. Quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy.

Authors:  H A Quigley; E M Addicks; W R Green
Journal:  Arch Ophthalmol       Date:  1982-01

10.  Correction for corneal polarization axis improves the discriminating power of scanning laser polarimetry.

Authors:  David S Greenfield; Robert W Knighton; William J Feuer; Joyce C Schiffman; Linda Zangwill; Robert N Weinreb
Journal:  Am J Ophthalmol       Date:  2002-07       Impact factor: 5.258

View more
  4 in total

1.  GDx VCC measurements and blue-on-yellow perimetry in ocular hypertension.

Authors:  Yisheng Zhong; Liping Chen; Yu Cheng; Fangzhi Yu
Journal:  Lasers Med Sci       Date:  2012-02-03       Impact factor: 3.161

2.  Correlation between blue-on-yellow perimetry and scanning laser polarimetry with variable corneal compensation measurements in primary open-angle glaucoma.

Authors:  Yisheng Zhong; Liping Chen; Yu Cheng; Ping Huang
Journal:  Jpn J Ophthalmol       Date:  2009-12-18       Impact factor: 2.447

3.  Optic nerve head and retinal nerve fiber layer analysis: a report by the American Academy of Ophthalmology.

Authors:  Shan C Lin; Kuldev Singh; Henry D Jampel; Elizabeth A Hodapp; Scott D Smith; Brian A Francis; David K Dueker; Robert D Fechtner; John S Samples; Joel S Schuman; Don S Minckler
Journal:  Ophthalmology       Date:  2007-10       Impact factor: 12.079

Review 4.  Confocal scanning laser ophthalmoscopy in glaucoma diagnosis and management.

Authors:  C Alexandrescu; A M Dascalu; A Panca; A Sescioreanu; C Mitulescu; R Ciuluvica; L Voinea; C Celea
Journal:  J Med Life       Date:  2010 Jul-Sep
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.